Ki Sung Hwan, Choi Min Jung, Lee Chang Ho, Kim Sang Geon
National Research Laboratory, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742, Korea.
J Biol Chem. 2007 Jan 19;282(3):1938-47. doi: 10.1074/jbc.M606080200. Epub 2006 Nov 10.
Cyclooxygenase-2 (COX-2) plays a critical role in vasodilatation and local inflammatory responses during platelet aggregation and thrombosis. Sphingosine 1-phosphate (S1P), a sphingolipid released from activated platelets, stimulates COX-2 induction and activates G-protein-coupled receptors coupled to Galpha family members. In this study, we investigated whether Galpha(12) family regulates COX-2 induction by S1P and investigated the molecular basis of this COX-2 regulation. Gene knock-out and chemical inhibitor experiments revealed that the S1P induction of COX-2 requires Galpha(12) but not Galpha(13), Galpha(q), or Galpha(i/o). The specific role of Galpha(12) in COX-2 induction by S1P was verified by promoter luciferase assay, Galpha(12) transfection, and knockdown experiments. Experiments using siRNAs specifically directed against S1P(1-5) showed that S1P(1), S1P(3), and S1P(5) are necessary for the full activation of COX-2 induction. Gel shift, immunocytochemistry, chromatin immunoprecipitation, and NF-kappaB site mutation analyses revealed the role of NF-kappaBin COX-2 gene transcription by S1P. Galpha(12) deficiency did not affect S1P-mediated IkappaBalpha phosphorylation but abrogated IkappaBalpha ubiquitination and degradation. Moreover, the inhibition of S1P activation of JNK abolished IkappaBalpha ubiquitination. Consistently, JNK transfection restored the ability of S1P to degrade IkappaBalpha during Galpha(12) deficiency. S1P injection induced COX-2 in the lungs and livers of mice and increased plasma prostaglandin E(2), and these effects were prevented by Galpha(12) deficiency. Our data indicate that, of the Galpha proteins coupled to S1P receptors, Galpha(12) specifically regulates NF-kappaB-mediated COX-2 induction by S1P downstream of S1P(1), S1P(3), and S1P(5), in a process mediated by the JNK-dependent ubiquitination and degradation of IkappaBalpha.
环氧化酶-2(COX-2)在血小板聚集和血栓形成过程中的血管舒张和局部炎症反应中起关键作用。鞘氨醇-1-磷酸(S1P)是一种从活化血小板释放的鞘脂,可刺激COX-2的诱导并激活与Gα家族成员偶联的G蛋白偶联受体。在本研究中,我们调查了Gα12家族是否调节S1P诱导的COX-2,并研究了这种COX-2调节的分子基础。基因敲除和化学抑制剂实验表明S1P诱导COX-2需要Gα12,而不是Gα13、Gαq或Gαi/o。通过启动子荧光素酶测定、Gα12转染和敲低实验验证了Gα12在S1P诱导COX-2中的特定作用。使用特异性针对S1P1-5的小干扰RNA(siRNA)进行的实验表明,S1P1、S1P3和S1P5是COX-2诱导完全激活所必需的。凝胶迁移、免疫细胞化学、染色质免疫沉淀和NF-κB位点突变分析揭示了NF-κB在S1P诱导COX-2基因转录中的作用。Gα12缺陷不影响S1P介导的IκBα磷酸化,但消除了IκBα的泛素化和降解。此外,抑制S1P对JNK的激活消除了IκBα的泛素化。一致地,JNK转染恢复了S1P在Gα12缺陷期间降解IκBα的能力。S1P注射可诱导小鼠肺和肝中的COX-2,并增加血浆前列腺素E2,而这些作用可被Gα12缺陷所阻止。我们的数据表明,在与S1P受体偶联的Gα蛋白中,Gα12在S1P1、S1P3和S1P5下游通过JNK依赖的IκBα泛素化和降解过程,特异性调节S1P介导的NF-κB诱导的COX-2。